| Literature DB >> 31775881 |
Yutaka Yamada1, Chiharu Kinoshita2, Hirokazu Nakagawa3.
Abstract
BACKGROUND: Actinomycosis is a chronic, slowly progressive infection caused by the Actinomyces species. Lumbar vertebral involvement of Actinomyces israelii is extremely rare; this is the first case report of lumbar vertebral osteomyelitis and psoas abscess caused by Actinomyces israelii after an operation under general anesthesia. CASEEntities:
Keywords: Actinomyces israelii; General anesthesia tracheal intubation; Nasogastric tube; Psoas abscess; Vertebral osteomyelitis
Mesh:
Year: 2019 PMID: 31775881 PMCID: PMC6881975 DOI: 10.1186/s13256-019-2261-y
Source DB: PubMed Journal: J Med Case Rep ISSN: 1752-1947
Fig. 1Computed tomography of lumbar spine and psoas abscess on day 5, the day after meropenem and vancomycin were initiated. a A coronal image showing low density area in the lateral part of left psoas major; b a sagittal image showing several bone pieces in the intervertebral area of L2/L3 and swelling of the disc. Although he had received two prior surgeries in his lower lumbosacral spine from L4 to S2, there was neither fracture nor abscess around the instruments
Fig. 2Gram stain and culture of the aspirate from L2/L3 intervertebral disk. a Gram stain showed multiple neutrophils and a few thin filamentous Gram-positive rods, and b small whitish colonies on sheep blood agar. The isolate was identified as Actinomyces israelii
Minimum inhibitory concentrations of Actinomyces israelii strain isolated from the aspirate
| Antibiotics | MIC | Susceptibility |
|---|---|---|
| Penicillin | ≤ 0.03 | Susceptible |
| Ampicillin | ≤ 0.03 | Susceptible |
| Ampicillin-sulbactam | ≤ 2 | Susceptible |
| Amoxicillin-clavulanate | ≤ 2 | Susceptible |
| Piperacillin-tazobactam | ≤ 16 | Susceptible |
| Ceftizoxime | ≤ 2 | Susceptible |
| Cefmetazole | ≤ 1 | Susceptible |
| Imipenem | ≤ 0.25 | Susceptible |
| Meropenem | ≤ 0.25 | Susceptible |
| Clindamycin | 0.25 | Susceptible |
| Chloramphenicol | ≤ 0.5 | Susceptible |
MIC minimum inhibitory concentration. Antibiotics susceptibilities were based on Clinical and Laboratory Standards Institute (CLSI) M100-S26
Fig. 3Computed tomography showed the gradual reduction of the left psoas abscess. a Day 5, the day after meropenem and vancomycin were initiated, b day 49, and c day 88